Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 159 participants.

Also called NCT02541877

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 159 participants (planned count) (from the registry)
Sponsor
Jian'an Wang,MD,PhD (from the registry)
Registry
  • NCT NCT02541877
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02541877. Randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2018-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve
Acronym
START
Condition
Aortic Valve Stenosis
Intervention (Device)
Down sizing valve in type-0 BAS
Intervention (Device)
Standard sizing valve in type-0 BAS
Intervention (Device)
Standard sizing valve in TAS
Lead sponsor
Jian'an Wang,MD,PhD (class: other)

Record details

Record id
cardio:ct-nct02541877
Content hash
7afbf5f1fb013630c92bb2500691794e72f816c34b6d908b51f01b3f494788d9